John Evans

About John Evans

The provided website for John Evans, mvalaw.com, is a law firm website and does not contain personal information about John Evans as an investor. It highlights the firm's legal services, recognitions, and community involvement. Therefore, a bio for John Evans as an investor cannot be extracted from this context.

John Evans at a glance

Role

Angel Investor

Location

Cambridge, MA, United States

Investor type

Individual/Angel

Focus areas

Mr. Evans joined Agios in September 2009. He possesses more than 10 years of biopharmaceuticals industry experience across a wide range of business functions. Prior to joining Agios, Mr. Evans served as director of product development at Infinity Pharmaceuticals where he led the company's most advanced oncology programs targeting Hsp90. He also established Infinity’s program management, new product planning and investor relations functions. Before Infinity, Mr. Evans held positions in the pharmaceuticals practice of McKinsey & Company, at MedImmune and at Bayer Pharmaceuticals. Mr. Evans earned an MBA in healthcare management from Wharton, a Masters in biotechnology from the University of Pennsylvania, and a B.A. in English from Yale University.

Frequently asked about John Evans

What does John Evans invest in?

John Evans (Cambridge, MA, United States) — sector focus: Mr. Evans joined Agios in September 2009. He possesses more than 10 years of biopharmaceuticals industry experience across a wide range of business functions.….

How do I contact John Evans?

John Evans's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.

Where is John Evans headquartered?

John Evans is based in Cambridge, MA, United States.

StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Cambridge.

Investors similar to John Evans (40)

• Boyu Capital Investment Management Co., Limited
• Deep Shah
• Samiz Bayan
• firstminute capital IV General Partner LLP
• Anar Chudgar
• Richard A. Friedman
• Jason Parikh
• Norbert Majerholc
• Dahna Goldstein
• Oep Ix-B GP S.A R.L.
• Readout Capital Fund GP, LLC
• Peter Y. Chung
• Michigan Capital Network Ventures, LLC
• Hermann Hauser
• George Watts
• Peter Debaz
• firstminute capital III General Partner LLP
• Joakim Alessandro Lindstrom-Formicola
• Aaron Perrine
• Matthew J. Hall
• Andrew L. Walker
• Steven G. Glenn
• Jamie Koven
• Vumindaba Dube
• Max F. Miller
• HMI Capital Fund GP, LLC
• Sandalwood Securities Inc.
• Whitney Ehrlich
• David Jaffe
• Future Capital Select Fund I GP Limited
• Kristin Hester
• Fund GP, LLC
• Kelly Alan
• Alan Kaplan
• Rafael Honorio Bassani
• David Lippin
• Lance Rosina
• John Robert Carroll
• Renovus GP IV SBIC, LLC
• H. Kim Lee

Browse related investor lists (6)

• Investors in Cambridge, MA, United States
• Biotech investors
• Biotech investors in Cambridge, MA, United States
• Healthcare investors
• Healthcare investors in Cambridge, MA, United States
• Individual Angel investors

Compare John Evans (8)

• John Evans vs Boyu Capital Investment Management Co., Limited
• John Evans vs Deep Shah
• John Evans vs Samiz Bayan
• John Evans vs firstminute capital IV General Partner LLP
• John Evans vs Anar Chudgar
• John Evans vs Richard A. Friedman
• John Evans vs Jason Parikh
• John Evans vs Norbert Majerholc

Investors like John Evans · Full investor directory · Investor access · Company funding database